Press Releases

Rheonix to Pursue Rapid Zika Virus Diagnostic

ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, in collaboration with New York University College of Dentistry (NYUCD), has received funding to develop a rapid diagnostic for Zika virus infection. The $656,414 award is an administrative supplement to an existing Small Business Innovation Research (SBIR) Phase I/II Fast-track grant from the National Institute of Dental and Craniofacial Research (NIDCR) of the National Institutes of Health… Read More »

Rheonix Develops Fully Automated Microfluidic System that Improves HIV Testing

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, has completed development and testing of a microfluidic system and assay to simultaneously detect host anti-HIV antibodies and viral RNA in a single specimen of saliva or blood. The company’s findings are outlined in the recently published research article, “A Rapid, Self-confirming Assay for HIV: Simultaneous Detection of Anti-HIV Antibodies and Viral RNA” in the Journal of… Read More »

Rheonix to Present on Industrial Automation Solutions in the Lab at SLAS 2016

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will showcase its breakthrough molecular testing workstation, the Encompass Optimum™, in booth 537 at the Society for Laboratory Automation and Screening’s (SLAS) fifth annual conference and exhibition. The exhibition will be held at the San Diego Convention Center, Jan. 23-27. Rheonix will also participate in Festo Corp.’s workshop, “How Industrial Automation Solutions Improve Processes in the Lab… Read More »
Latest News »

Press Archives